Engineered Extracellular Vesicles: Tailored-Made Nanomaterials for Medical Applications

• Published in: Nanomaterials (Basel, Switzerland) Vol. 10; no. 9; p. 1838
• Main Authors: Man, Kenny, Brunet, Mathieu Y., Jones, Marie-Christine, Cox, Sophie C.
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 15.09.2020; MDPI
• Subjects: Angiogenesis; Apoptosis; Biomaterials; Biomedical materials; Biomimetics; Biosynthesis; Cell interactions; Efficiency; Engineering; Enzymes; EV engineering; exosomes; Extracellular vesicles; Genomes; Heterogeneity; Homeostasis; Hydrogels; Immunogenicity; microvesicles; Nanomaterials; nanomedicine; Nanoparticles; Nanotechnology; Plasma; Proteins; Regeneration (physiology); regenerative medicine; Review; Tissue engineering; Vesicles
• ISSN: 2079-4991; 2079-4991
• DOI: 10.3390/nano10091838

Extracellular vesicles (EVs) are emerging as promising nanoscale therapeutics due to their intrinsic role as mediators of intercellular communication, regulating tissue development and homeostasis. The low immunogenicity and natural cell-targeting capabilities of EVs has led to extensive research investigating their potential as novel acellular tools for tissue regeneration or for the diagnosis of pathological conditions. However, the clinical use of EVs has been hindered by issues with yield and heterogeneity. From the modification of parental cells and naturally-derived vesicles to the development of artificial biomimetic nanoparticles or the functionalisation of biomaterials, a multitude of techniques have been employed to augment EVs therapeutic efficacy. This review will explore various engineering strategies that could promote EVs scalability and therapeutic effectiveness beyond their native utility. Herein, we highlight the current state-of-the-art EV-engineering techniques with discussion of opportunities and obstacles for each. This is synthesised into a guide for selecting a suitable strategy to maximise the potential efficacy of EVs as nanoscale therapeutics.